Mike Dutra is a Managing Director and Senior Investment Officer in the Life Sciences Group working in the Boston office. He is focused on transactions with a broad range of private and public healthcare companies including biotechnology, specialty pharmaceuticals, medical device, innovative services, and other healthcare companies at all stages of development.

Mike joined Hercules in June 2014 and was most recently promoted to Managing Director in January 2021. Prior to Hercules, he held positions with Goldman Sachs as an Operations Analyst and with DePuy Synthes as a Quality Engineer.

Mike graduated with honors from Northeastern University with a B.S. in Industrial Engineering.